Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19?

The COVID-19 pandemic caused by the SARS-CoV-2 virus has infected millions and overburdened the healthcare infrastructure globally. Recent studies show that the endothelial dysfunction caused by the virus contributes to its high morbidity and mortality. A parameter that can identify patients who wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoganandamoorthy, Sarangini, Munasinghe, M.A.D.S.N., Wanigasuriya, L.V.U., Priyankara, M.K.K., Jayasinghe, Saroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466972/
https://www.ncbi.nlm.nih.gov/pubmed/33254535
http://dx.doi.org/10.1016/j.mehy.2020.110229
Descripción
Sumario:The COVID-19 pandemic caused by the SARS-CoV-2 virus has infected millions and overburdened the healthcare infrastructure globally. Recent studies show that the endothelial dysfunction caused by the virus contributes to its high morbidity and mortality. A parameter that can identify patients who will develop complications early will be valuable in patient management and reducing the burden on medical resources. An emerging technology is currently being tested to predict the cardiovascular risk via non-invasively measuring the endothelial dysfunction. This paper reviews how the assessment of endothelial dysfunction using this technology can be used as a potential parameter in the prognostication and management of COVID-19 patients.

Ejemplares similares